Andrzej Swistowski

WORK HISTORY

EDUCATION

SKILLS

ABOUT ANDRZEJ SWISTOWSKI

Accomplished and results‑driven biotechnology leader with extensive experience guiding preclinical drug development programs, particularly for rare genetic diseases with CNS involvement. Demonstrated success in steering complex projects from early discovery through IND‑enabling studies, with deep expertise in target identification, therapeutic opportunity evaluation, and rigorous due diligence and risk assessment. Highly skilled in orchestrating cross‑functional teams and applying robust, stage‑gated project management methodologies to ensure seamless transitions between program milestones. Adept at translating scientific insights into clear development strategies, optimizing study design, proactively mitigating risks, and aligning resources to accelerate timelines and enhance portfolio value. Brings a broad and integrated scientific foundation across neuroscience, stem cell biology, molecular biology, and genetic engineering, supported by strong technical capabilities in in vitro disease modeling, assay development, and biochemical characterization. Known for a patient‑centric mindset balanced with a strong appreciation of business priorities, enabling effective identification and advancement of high‑potential therapeutic assets. Recognized for exceptional communication, collaboration, and team‑building skills, combined with a commitment to scientific integrity and organizational excellence. Deep interest and subject‑matter expertise in neurodevelopmental, neurodegenerative, neuromuscular, and lysosomal storage disorders—especially those with CNS pathology—as well as metabolic diseases and innovative therapeutic platforms.